PPCO Insider Trading Activity and SEC Form 4 Filings
PPCO insider trading summary
No open-market insider purchases or sales of Penwest Pharmaceuticals Co (PPCO) have been reported on SEC Form 4 in the past 12 months.
Latest PPCO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2010 | Endo Pharmaceuticals Holdings Inc | 10% Owner | Buy | $0 (3,173,334 @ $0.00) |
| Nov 4, 2010 | West Acquisition Corp. | 10% Owner | Buy | $0 (3,173,334 @ $0.00) |
| Nov 11, 2009 | Jennifer L Good | President & CEO | Buy | $16K (7,500 @ $2.14) |
| Sep 3, 2009 | Paul E Freiman | Director | Sell | $8K (3,466 @ $2.35) |
| Mar 11, 2009 | Kevin C Tang | 10% Owner | Buy | $5K (4,100 @ $1.30) |
| Mar 11, 2009 | Tang Capital Partners LP | 10% Owner | Buy | $29K (21,000 @ $1.36) |
| Mar 11, 2009 | Tang Capital Partners LP | 10% Owner | Buy | $5K (4,100 @ $1.30) |
| Mar 11, 2009 | Tang Capital Management LLC | 10% Owner | Buy | $29K (21,000 @ $1.36) |
| Mar 11, 2009 | Tang Capital Management LLC | 10% Owner | Buy | $5K (4,100 @ $1.30) |
| Mar 11, 2009 | Kevin C Tang | 10% Owner | Buy | $29K (21,000 @ $1.36) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.